NCT00000289View on ClinicalTrials.gov

Role of Metabolites in Nicotine Dependence (3) - 6

PHASE2CompletedINTERVENTIONAL
0
Timeline

Start Date

May 31, 1998

Study Completion Date

December 31, 2001

Conditions
Tobacco Use Disorder
Interventions
DRUG

Ondansetron

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

University of Minnesota

OTHER

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00000289 - Role of Metabolites in Nicotine Dependence (3) - 6 | Biotech Hunter | Biotech Hunter